Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Triclabendazole; Levamisole hydrochloride
Elanco GmbH
QP52AC30
Triclabendazole; Levamisole hydrochloride
19.5 percent weight/volume
Oral suspension
POM: Prescription Only Medicine as defined in relevant national legislation
combinations of benzimidazoles and related substances
Authorised
2016-10-21
Health Products Regulatory Authority 21 August 2018 CRN008DKW Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Endex 19.5 % w/v Oral Suspension for Cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Triclabendazole 12.0 % w/v Levamisole hydrochloride 7.5 % w/v Excipients Methyl parahydroxybenzoate E218 0.08 % w/v Propyl parahydroxybenzoate E216 0.03 % w/v Benzoic acid E210 0.1 % w/v Sodium metabisulphite E223 0.25 % w/v For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. A white to off-white aqueous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the simultaneous treatment and control of mature and developing immature infections of stomach worms _(Haemonchus, Ostertagia, Trichostrongylus axei_), gut worms (_Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum_) and lung worms (_Dictyocaulus)_ as well as all forms of liver fluke infection (early immature, immature and adult stages of _Fasciola hepatica_ and _Fasciola gigantica_) in cattle. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients. Do not use for the control of inhibited Type II Ostertagia infestations. Health Products Regulatory Authority 21 August 2018 CRN008DKW Page 2 of 5 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Endex 19.5% is not suitable for sheep. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The product is effective on the mature and developing immature stages of Ostertagia, but is not indicated for the control of inhibited larvae (i.e. Type II ostertagiasis). SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Wash hands after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known. 4.7 USE DURING PREGNANCY, LACTATION OR LAY The product is Read the complete document